Post on 03-Dec-2021
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
TATALAKSANA RASIONAL LIKEN SIMPLEKS KRONIKUS
dr. Agustina Tri Pujiastuti SpKK
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
OUTLINE
DEFINISI PATOGENESA MANIFESTASI KLINIS DIAGNOSIS TATALAKSANA PROGNOSIS
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
DEFINISI
• Liken Simpleks Kronikus (LSK): Suatu peradangan kulit kronik yang sangat gatal berupa penebalan kulit dan likenifikasi berbentuk sirkumskripta, akibat garukan berulang
• Nama lain : Neurodermatitis Sirkumskripta • ICD 10 : L28
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
Epidemiologi
• 12% populasi dunia menderita penyakit liken simplex kronikus/neurodermatitis
• Umumnya terjadi pada usia 30 hingga 50 tahun
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
PATOGENESA
Penebalan kulit dan
likenifikasi
Gosokan/
Rubbing
Garukan/
Scratching
PRURITUS (SEKUNDER/KRONIS)
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
Faktor Pencetus Pruritus
Kelainan Kulit
• Dermatitis Atopik
• Superimposed pada dermatosis lain misalnya psoriasis, dermatitis kontak, ineksi kandida dan tinea
Psikologis
• Gangguan anxietas
• Depresi
• Obsessive-compulsive disorder
Kelainan Sistemik
• Renal insufficiency
• Hiper- or hipotiroid
• Liver failure
• Hepatitis B and C
• HIV
• Infeksi Helicobacter, mycobacterial atau parasit
• Keganasan hematologi atau organ padat
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
ANAMNESIS
• Gatal - Bisa paroksimal /terus menerus/sporadik - Eksaserbasi saat stres
• Dapat mengganggu tidur
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
Manifestasi Klinis
• Predileksi : daerah yang mudah dijangkau tangan seperti kulit kepala, tengkuk, ekstremitas ekstensor, pergelangan tangan, dan area anogenital (vulva, skrotum, perianal)
• Lesi kulit berupa likenifikasi - Dapat tunggal atau multipel - Ukuran lentikular hingga plakat
Eritema/edema/
papul/pustule
Plak likenifikasi dengan skuama dan ekskoriasi, hiperpigmentasi
atau hipopigmentasi
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
Lichen Simplex Nuchae
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
PEMERIKSAAN PENUNJANG 1. Pemeriksaan Histopatologi • Berbagai derajat hiperkeratosis dengan
parakeratosis dan orthokeratosis, hipergranulosis dan hiperplasia epidermis psoriasiformis
• Penebalan kolagen dengan bundle kolagen kasar dan garis vertikal pada papila dermis
• Infiltrat sel inflamasi seperti limfosit, histiosit dan eosinofil pada sekitar plexus vaskular
Torales J, Barrios I, Lezcano L and Di Martino B. Lichen Simplex Chronicus: Easy Psychological Interventions that Every Dermatologist Should Know. SM J Dermatolog. 2016; 2(1): 1005
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
2. Pemeriksaan lain sesuai diagnosis banding, seperti imunofluoresens direk, pemeriksaan KOH, patch test
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
DIAGNOSIS BANDING
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
TATA LAKSANA
Identifikasi penyakit
yang mendasari
Perbaiki fungsi lapisan
barier kulit
Kurangi inflamasi
Putuskan siklus gatal-
garuk
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
TATA LAKSANA
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
KORTIKOSTEROID TOPIKAL
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
STUDY OBJECTIVE CONCLUSION
Guzzo CA, Weiss JS, Mogavero HS, et al. A review of two controlled multicenter trials comparing 0.05% halobetasol propionate ointment to its vehicle in the treatment of chronic eczematous dermatoses. Journal of the American Academy of Dermatology. 1991;25(6):1179-1183. Kantor I, Cook PR, Cullen SI, Willis I, Gibson JR, Stanfield JW. Double-blind bilateral paired comparison of 0.05% halobetasol propionate cream and its vehicle in patients with chronic atopic dermatitis and other eczematous dermatoses. J Am Acad Dermatol. 1991;25(6 Pt 2):1184-1186.
The efficacy of halobetasol propionate in reducing disease severity in patients with LSC
Significant reduction in pruritus, erythema, scaling, and lichenification in treated patients compared to controls
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
STUDY OBJECTIVE CONCLUSION
Datz B, Yawalkar S. A double-blind, multicenter trial of 0.05% halobetasol propionate ointment and 0.05% clobetasol 17-propionate ointment in the treatment of patients with chronic, localized atopic dermatitis or lichen simplex chronicus. Journal of the American Academy of Dermatology. 1991;25(6 II SUPPL.):1157- 1160 Brunner N, Yawalkar S. A double-blind,multicenter, parallel-group trial with 0.05% halobetasol propionate ointment versus 0.1% diflucortolone valerate ointment in patients with severe, chronic atopic dermatitis or lichen simplex chronicus. Journal of the American Academy of Dermatology. 1991;25(6 II SUPPL.):1160-1163
Comparing the efficacy of halobetasol propionate to diflucortolone valerate and clobetasol 17-propionate respectively
Halobetasol had higher success rates and onset of action compared to diflucortolone, and higher healing rates than clobetasol, though these results were not statistically significant
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
STUDY OBJECTIVE CONCLUSION
Rajan VS. Controlled double blind trial with supracortin cream. Singapore Medical Journal. 1976;17(4):216-218
Compare the efficacy of once daily application of fluprednidene- 21-acetate to thrice daily application of betamethasone 17-valerate
No significant differences in the reduction of symptomatology scores were noted in either group after 2 weeks of treatment (mean change in score 5.3 for fluprednylidene-21-acetate and 3.8 for betamethasone p=.17) suggesting that fluprednylidene applied once daily was as effective as thrice daily application of betamethasone, allowing for smaller quantities of a potent steroids to be applied with potentially fewer side effects
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
STUDY OBJECTIVE CONCLUSION
Geraldez MCB, Carreon‐Gavino M, Hoppe G, Costales A. Diflucortolone Valerate Ointment With and Without Occlusion in Lichen Simplex Chronicus. International Journal of Dermatology. 1989;28(9):603- 604
The utility of occlusion as adjunctive therapy with topical corticosteroids
A significantly lower improvement of lichenification and pruritus (p<.001 for both) and even led to development of more side effects
Volden G. Successful treatment of chronic skin diseases with clobetasol propionate and a hydrocolloid occlusive dressing. Acta Dermato-Venereologica. 1992;72(1):69-71
Once weekly application of clobetasol propionate and duoderm occlusive dressing led to complete remission of disease in 89% patients in two weeks
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
EFEK SAMPING KORTIKOSTEROID TOPIKAL
• Atrofi kulit • Reaksi akneiformis
• Perubahan pigmentasi • Hipertrikosis • Infeksi kulit • Reaksi alergi
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
PREPARAT ANTIPRURITUS NON STEROID
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
STUDY OBJECTIVE CONCLUSION
Drake LA, Millikan LE. The antipruritic effect of 5% doxepin cream in patients with eczematous dermatitis. Doxepin Study Group. Arch Dermatol. 1995;131(12):1403-1408
Assess the efficacy of doxepin cream applied four times daily for one week in reducing pruritus in patients with LSC
Significantly more patients in the treatment arm had improved pruritus severity scores compared to controls at 1 day and one week of treatment (45% vs 23% respectively within 24 hrs, p=.01, and 76.5% vs 57% respectively within one week, p=.01) as well as a significant improvement in physician global evaluation for pruritus relief scores (p=.003)
Breneman DL, Dunlap FE, Monroe EW, Schupbach CW, Shmunes E, Phillips SB. Doxepin cream relieves eczema-associated pruritus within 15 minutes and is not accompanied by a risk of rebound upon discontinuation. Journal of Dermatological Treatment. 1997;8(3):161-168
Investigating the onset of action of topical doxepin and whether discontinuation of therapy would be associated with rebound worsening
Onset of action occurred within 15 minutes of application (p<.001) and sustained reductions in pruritus occured through one week of treatment. Additionally, no rebound effect was seen after discontinuing therapy with doxepin cream (p<.001)
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
Calcineurin Inhibitor Topikal
• Salep Takrolimus 0,1% • Krim Pimekrolimus 0,1%
2x sehari selama 12 minggu
Risiko rendah terjadi atrofi dan striea → utamanya untuk studi LSK genital
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
STUDY OBJECTIVE CONCLUSION
Goldstein AT, Parneix-Spake A, McCormick CL, Burrows LJ. Pimecrolimus cream 1% for treatment of vulvar lichen simplex chronicus: An open-label, preliminary trial. Gynecologic and Obstetric Investigation. 2007;64(4):180-186
Observational studies : the efficacy of immunomodulators in treating genital LSC across
Complete resolution of pruritus by week 4 of treatment with sustained resolution until the end of treatment at 12 weeks. Disease severity scores as measured by the Investigators Global Assessment (IGA) decreased from a moderate-tosevere baseline score to no disease by the end of treatment with concomitant improvements in erythema, excoriation, and lichenification for all patients
Kelekci HK, Uncu HG, Yilmaz B, Ozdemir O, Sut N, Kelekci S. Pimecrolimus 1% cream for pruritus in postmenopausal diabetic women with vulvar lichen simplex chronicus: A prospective non-controlled case series. Journal of Dermatological Treatment. 2008;19(5):274-278
Significant decreases in pruritus by 4 and 12 weeks of treatment compared to baseline (pruritus score 3.75 at baseline, 2.17 at 4 weeks p<.01, 0.42 at 12 weeks p<.001) and complete cure of disease in 83% of treated patients
Tan E, Tey HL, Tan ES, Tan AS. Tacrolimus ointment 0.1% in the treatment of scrotal lichen simplex chronicus: An open-label study. Annals of the Academy of Medicine Singapore. 2013;42(9):S284
0.1% topical tacrolimus significantly decreased mean itch scores, itch frequency, and overall affected surface area after treatment (p<.001 for all) in 40 patients with scrotal LSC
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
FOTOTERAPI STUDY OBJECTIVE CONCLUSION
Esen Salman K, Kivanc Altunay I, Salman A. The efficacy and safety of targeted narrowband UVB therapy: a retrospective cohort study. Turkish journal of medical sciences. 2019;49(2):595-603.
Weekly treatments of NBUVB in patients with LSC resistant to prior topical treatment
After a mean of 29 treatment sessions, complete response (>90% improvement) occurred in 30% of patients, and 73.8% of patients showed moderate or better (>50% improvement) responses. Additionally, there was a 75% improvement in mean pruritus scores. Side effects were minimal and primarily included erythema
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
Emolien
• Dapat sebagai kombinasi dengan kortikosteroid topikal
• Sebagai terapi tunggal pada lesi di vulva
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
SISTEMIK
• Antihistamin sedatif • Antidepresan trisiklik
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
TINDAKAN
• Kortikosteroid intralesi (triamsinolon asetonid) : 3-10mg/ml
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com
PROGNOSIS
• Kronis • Durasi rata-rata LSK : 30.6 bulan • Apabila berhubungan dengan penyakit sistemik→
durasi lebih lama • Eksaserbasi dikaitkan dengan respon terhadap stres
dan stimuli eksogen
This presentation uses a free template provided by FPPT.com www.free-power-point-templates.com